Large gap with delayed quotes
Analysis date: 13.03.2026
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 13.02.2026.
Interest
Strong
Strong
Three stars since 27.02.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 13.02.2026 at a price of 75.87.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 27.02.2026.
4wk Rel Perf
10.81%
10.81%
The four-week dividend-adjusted overperformance versus SP500 is 10.81%.
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 04.04.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.60%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.04%.
Mkt Cap in $bn
47.52
47.52
With a market capitalization >$8bn, EDWARDS LIFESCIENCES is considered a large-cap stock.
G/PE Ratio
0.81
0.81
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
21.36
21.36
The estimated PE is for the year 2028.
LT Growth
17.27%
17.27%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
25
25
Over the last seven weeks, an average of 25 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
62
62
For 1% of index variation, the stock varies on average by 0.62%.
Correlation
0.47
0.47
46.54% of stock movements are explained by index variations.
Value at Risk
5.58
5.58
The value at risk is estimated at USD 5.58. The risk is therefore 6.82%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002